BaroFold, Inc. Awarded Patent For Using High Pressure To Improve The Safety Profile Of Biologic Drugs

AURORA, Colo.--(BUSINESS WIRE)--BaroFold, Inc. today announced it was awarded U.S. Patent No. 8,697,848, entitled “Method for reducing immunogenicity of therapeutic protein compositions,” which provides additional protections over the company’s Pressure Enabled Protein Manufacturing Technology (PreEMT™). PreEMT is being used by BaroFold’s industry partners to improve the tolerability, efficacy and safety of a wide variety of protein therapeutics.

Help employers find you! Check out all the jobs and post your resume.